Download
s00392-020-01757-z.pdf 1,56MB
WeightNameValue
1000 Titel
  • Early results of a real-world series with two transapical transcatheter mitral valve replacement devices
1000 Autor/in
  1. Ludwig, Sebastian |
  2. Kalbacher, D. |
  3. Schofer, N. |
  4. Schäfer, A. |
  5. Koell, B. |
  6. Seiffert, M. |
  7. Schirmer, J. |
  8. Schäfer, U. |
  9. Westermann, D. |
  10. Reichenspurner, H. |
  11. Blankenberg, S. |
  12. Lubos, E. |
  13. Conradi, L. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-19
1000 Erschienen in
1000 Quellenangabe
  • 110(3):411-420
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00392-020-01757-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907022/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Aims!#!Transcatheter mitral valve replacement (TMVR) with dedicated devices promises to fill the treatment gap between open-heart surgery and edge-to-edge repair for patients with severe mitral regurgitation (MR). We herein present a single-centre experience of a TMVR series with two transapical devices.!##!Methods and results!#!A total of 11 patients were treated with the Tendyne™ (N = 7) or the Tiara™ TMVR systems (N = 4) from 2016 to 2020 either as compassionate-use procedures or as commercial implants. Clinical and echocardiographic data were collected at baseline, discharge and follow-up and are presented in accordance with the Mitral Valve Academic Research Consortium (MVARC) definitions. The study cohort [age 77 years (73, 84); 27.3% male] presented with primary (N = 4), secondary (N = 5) or mixed (N = 2) MR etiology. Patients were symptomatic (all NYHA III/IV) and at high surgical risk [logEuroSCORE II 8.1% (4.0, 17.4)]. Rates of impaired RV function (72.7%), severe pulmonary hypertension (27.3%), moderate or severe tricuspid regurgitation (63.6%) and prior aortic valve replacement (63.6%) were high. Severe mitral annulus calcification was present in two patients. Technical success was achieved in all patients. In 90.9% (N = 10) MR was completely eliminated (i.e. no or trace MR). Procedural and 30-day mortality were 0.0%. At follow-up NYHA class was I/II in the majority of patients. Overall mortality after 3 and 6 months was 10.0% and 22.2%.!##!Conclusions!#!TMVR was performed successfully in these selected patients with complete elimination of MR in the majority of patients. Short-term mortality was low and most patients experienced persisting functional improvement.
1000 Sacherschließung
lokal Female [MeSH]
lokal Mitral Valve/diagnostic imaging [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Mitral Valve Insufficiency/diagnosis [MeSH]
lokal Aged [MeSH]
lokal Mitral Valve Insufficiency/surgery [MeSH]
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Cardiac Catheterization/methods [MeSH]
lokal Retrospective Studies [MeSH]
lokal Risk Factors [MeSH]
lokal Time Factors [MeSH]
lokal Compassionate use
lokal Heart Valve Prosthesis [MeSH]
lokal Male [MeSH]
lokal Echocardiography [MeSH]
lokal Heart Valve Prosthesis Implantation/instrumentation [MeSH]
lokal Original Paper
lokal Transcatheter mitral valve replacement
lokal Equipment Design [MeSH]
lokal Mitral Valve/surgery [MeSH]
lokal Mitral regurgitation
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-5752-4951|https://frl.publisso.de/adhoc/uri/S2FsYmFjaGVyLCBELg==|https://frl.publisso.de/adhoc/uri/U2Nob2ZlciwgTi4=|https://frl.publisso.de/adhoc/uri/U2Now6RmZXIsIEEu|https://frl.publisso.de/adhoc/uri/S29lbGwsIEIu|https://frl.publisso.de/adhoc/uri/U2VpZmZlcnQsIE0u|https://frl.publisso.de/adhoc/uri/U2NoaXJtZXIsIEou|https://frl.publisso.de/adhoc/uri/U2Now6RmZXIsIFUu|https://frl.publisso.de/adhoc/uri/V2VzdGVybWFubiwgRC4=|https://frl.publisso.de/adhoc/uri/UmVpY2hlbnNwdXJuZXIsIEgu|https://frl.publisso.de/adhoc/uri/QmxhbmtlbmJlcmcsIFMu|https://frl.publisso.de/adhoc/uri/THVib3MsIEUu|https://frl.publisso.de/adhoc/uri/Q29ucmFkaSwgTC4=
1000 Hinweis
  • DeepGreen-ID: 70e3265915704c9085b9082e17df5c9a ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6469958.rdf
1000 Erstellt am 2023-11-18T02:55:04.089+0100
1000 Erstellt von 322
1000 beschreibt frl:6469958
1000 Zuletzt bearbeitet 2023-12-01T10:52:57.678+0100
1000 Objekt bearb. Fri Dec 01 10:52:57 CET 2023
1000 Vgl. frl:6469958
1000 Oai Id
  1. oai:frl.publisso.de:frl:6469958 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source